| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |